Expression and purification of soluble bacterially-expressed human hexokinase II in E.coli system

Human hexokinase II (HKII) is one of the key enzymes in the glycolytic pathway. It has been postulated that HKII is a potential target for anti-dengue (DENV) drug development, as well as involved in cancer and tumor cell growth. In this work, the human hexokinase II (HKII) gene was cloned into p...

Full description

Bibliographic Details
Main Authors: Tanbin, Suriyea, Ahmad Fuad, Fazia Adyani
Format: Proceeding Paper
Language:English
English
Published: Association for Computing Machinery 2019
Subjects:
Online Access:http://irep.iium.edu.my/79728/
http://irep.iium.edu.my/79728/9/79728_Expression%20and%20Purification%20of%20Soluble_new_complete.pdf
http://irep.iium.edu.my/79728/2/79728_Expression%20and%20Purification%20of%20Soluble%20Bacterially-Expressed_scopus.pdf
Description
Summary:Human hexokinase II (HKII) is one of the key enzymes in the glycolytic pathway. It has been postulated that HKII is a potential target for anti-dengue (DENV) drug development, as well as involved in cancer and tumor cell growth. In this work, the human hexokinase II (HKII) gene was cloned into pETite N-His SUMO vector and transformed into the E.coli strain HI-control 10G for the propagation of clones. Two different expression hosts, E.coli HI-controlTM BL21 (DE3) and BL21 (DE3) pLysS were used to optimize HKII expression. In order to obtain the soluble recombinant HKII in a functional form, we optimized protein expression at three different temperatures; 17°C, 25°C and 37°C, at 24 hours incubation time. The soluble protein was expressed in the presence of 0.5 mM isopropyl-2-Dthiogalactopyranoside (IPTG) in TB media at 17°C for 24 hrs. The expressed protein was then purified to homogeneity by a combination of Immobilized Metal Ion Affinity Chromatography (IMAC), size exclusion chromatography (SEC) and ion-exchange chromatography (IEX), resulting in pure bacterially-expressed HK2. Taken together, this study has successfully produced soluble bacterially-expressed human HKII that can be utilized for further therapeutic studies.